Riccardo Cortese

Q: What Schools Are Affiliated With Riccardo Cortese

Riccardo Cortese is affiliated with the following schools: University of Oslo, University of California, Berkeley, Boston University, University of Oxford, Rockefeller University

Riccardo Cortese's AcademicInfluence.com Rankings

Riccardo Cortese

Biology

#9852

World Rank

#13104

Historical Rank

Biotechnology

#131

World Rank

#133

Historical Rank

Virology

#230

World Rank

#237

Historical Rank

Molecular Biology

#1375

World Rank

#1402

Historical Rank

biology Degrees

Download Badge

Biology

Riccardo Cortese's Degrees

PhD Biomedical Sciences University of Milan
Masters Biotechnology University of Milan
Bachelors Biotechnology University of Milan

Why Is Riccardo Cortese Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Riccardo Cortese's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus (2002) (1253)
pEMBL: a new family of single stranded plasmids. (1983) (921)
Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor* (2003) (662)
IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C EBP (1990) (571)
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man (2012) (414)
The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain (1989) (410)
The crystal structure of the quorum sensing protein TraR bound to its autoinducer and target DNA (2002) (337)
Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. (1999) (332)
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees (2006) (328)
Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro* (2003) (319)
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge (2014) (318)
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. (2004) (314)
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory (2014) (301)
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA. (2015) (295)
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation (2013) (281)
Transcription by RNA polymerase III. (1983) (269)
A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. (1994) (243)
Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. (1993) (229)
Product inhibition of the hepatitis C virus NS3 protease. (1998) (226)
Prime-boost vectored malaria vaccines: Progress and prospects (2010) (217)
Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. (1997) (210)
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector (2012) (207)
Binding of the Hepatitis C Virus E2 Glycoprotein to CD81 Is Strain Specific and Is Modulated by a Complex Interplay between Hypervariable Regions 1 and 2 (2003) (207)
Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. (1988) (196)
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. (2012) (193)
Chimpanzee Adenovirus Vector Ebola Vaccine (2017) (192)
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T-Cell Responses (2009) (187)
Purification of a NF1‐like DNA‐binding protein from rat liver and cloning of the corresponding cDNA. (1988) (181)
Order and intracellular location of the events involved in the maturation of a spliced tRNA (1980) (180)
[Mutant tRNA His ineffective in repression and lacking two pseudouridine modifications]. (1972) (174)
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants (2009) (169)
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. (1999) (168)
The human alpha 1‐antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes. (1987) (168)
A fast and simple method for sequencing DNA cloned in the single-stranded bacteriophage M13. (1979) (167)
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products. (1998) (165)
Two distinct factors interact with the promoter regions of several liver‐specific genes. (1988) (164)
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein (2007) (162)
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors. (2011) (161)
Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors (2012) (160)
Two different liver‐specific factors stimulate in vitro transcription from the human alpha 1‐antitrypsin promoter. (1988) (160)
Structure and expression of the genes coding for human alpha 1‐acid glycoprotein. (1987) (157)
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. (2005) (156)
LFB3, a heterodimer‐forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. (1991) (155)
Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross‐reacting with a large number of viral variants (1998) (155)
The two C/EBP isoforms, IL6DBP/NFIL6 and CEBP6δ/NFIL63, are induced by IL6β to promote acute phase gene transcription via different mechanisms (1993) (152)
LFB1 and LFB3 homeoproteins are sequentially expressed during kidney development. (1992) (150)
Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries. (1993) (150)
The human haptoglobin gene promoter: interleukin‐6‐responsive elements interact with a DNA‐binding protein induced by interleukin‐6. (1989) (149)
The different tissue transcription patterns of genes for HNF-1, C/EBP, HNF-3, and HNF-4, protein factors that govern liver-specific transcription. (1991) (148)
Interleukin 6 induces a liver-specific nuclear protein that binds to the promoter of acute-phase genes. (1989) (146)
Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. (1995) (139)
A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo (2012) (139)
Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion. (2003) (135)
A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1 (1990) (129)
Epitope discovery using peptide libraries displayed on phage. (1994) (128)
Gene therapy progress and prospects: transcription regulatory systems (2004) (128)
Amino‐terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication. (1990) (125)
Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer (2000) (125)
Common and interchangeable elements in the promoters of genes transcribed by RNA polymerase III (1983) (123)
Selection of biologically active peptides by phage display of random peptide libraries. (1996) (122)
Identification of biologically active peptides using random libraries displayed on phage. (1995) (122)
Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals (2014) (121)
Structure and expression of the human haptoglobin locus. (1985) (119)
Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF1/LFB1. (1990) (117)
Induction of anti‐carbohydrate antibodies by phage library‐selected peptide mimics (1997) (115)
Biosynthesis of pseudouridine in transfer ribonucleic acid. (1974) (115)
Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults (2015) (112)
Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells (2008) (110)
Inhibition of Nipah Virus Infection In Vivo: Targeting an Early Stage of Paramyxovirus Fusion Activation during Viral Entry (2010) (108)
Site-Specific Integration in Mammalian Cells Mediated by a New Hybrid Baculovirus–Adeno-Associated Virus Vector (1998) (108)
The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism. (1999) (107)
Cis‐ and trans‐acting elements responsible for the cell‐specific expression of the human alpha 1‐antitrypsin gene. (1987) (104)
Cell-specific expression of a transfected human α1 -antitrypsin gene (1985) (103)
Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance (2004) (103)
Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda. (1998) (101)
Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization (2013) (101)
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH (2017) (100)
Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease. (1997) (99)
Modulation of the Immune Response Induced by Gene Electrotransfer of a Hepatitis C Virus DNA Vaccine in Nonhuman Primates (2006) (98)
Structure of gene and pseudogenes of human apoferritin H. (1986) (98)
Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. (2002) (97)
Structure of the human α1acid glycoprotein gene: sequence homology with other human acute phase protein genes (1985) (95)
A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques (2006) (95)
Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. (1996) (95)
The human haptoglobin gene: transcriptional regulation during development and acute phase induction. (1987) (90)
Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patients (2003) (89)
Cloning and sequencing of a full length cDNA coding for human retinol-binding protein. (1983) (89)
Dissecting the Biological Functions of Drosophila Histone Deacetylases by RNA Interference and Transcriptional Profiling* (2006) (88)
Viral Entry Inhibitors Targeted to the Membrane Site of Action (2010) (88)
Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector. (2000) (87)
Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials (2013) (87)
Negative control of liver‐specific gene expression: cloned human retinol‐binding protein gene is repressed in HeLa cells. (1987) (86)
Transcription factors and liver-specific genes. (1992) (86)
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. (2015) (84)
Biochemical and regulatory properties of Escherichia coli K-12 hisT mutants (1977) (83)
Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice. (2012) (83)
Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults (2013) (80)
Cloning of the gene coding for human L apoferritin. (1986) (80)
Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance (2006) (79)
Expression of human alpha 1-acid glycoprotein genes in cultured cells and in transgenic mice. (1988) (78)
Pleiotropy of hisT mutants blocked in pseudouridine synthesis in tRNA: leucine and isoleucine-valine operons. (1974) (77)
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates. (2010) (77)
Nucleotide sequence of rat liver HMG1 cDNA. (1987) (76)
Universal Influenza B Vaccine Based on the Maturational Cleavage Site of the Hemagglutinin Precursor (2005) (76)
Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates (2003) (75)
Cloning and sequencing of a full length cDNA coding for a human apoferritin H chain: evidence for a multigene family. (1984) (74)
Properties of a genetically engineered G domain of elongation factor Tu. (1987) (73)
Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. (1994) (72)
Molecular cloning of human LDL apolipoprotein B cDNA. Evidence for more than one gene per haploid genome. (1985) (71)
Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. (1996) (69)
pEMBL: a new family of single-stranded plasmids for sequencing DNA. (1987) (68)
A novel, inducible, eukaryotic gene expression system based on the quorum‐sensing transcription factor TraR (2003) (68)
Post‐transcriptional control of negative acute phase genes by transforming growth factor beta. (1989) (67)
The affinity‐selection of a minibody polypeptide inhibitor of human interleukin‐6. (1994) (67)
The primary structure of human hemopexin deduced from cDNA sequence: evidence for internal, repeating homology. (1985) (66)
A conformationally homogeneous combinatorial peptide library. (1995) (66)
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity (2012) (66)
The pEMBL family of single stranded vectors (1984) (65)
Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses (2014) (62)
The transcription factor LF-A1 interacts with a bipartite recognition sequence in the promoter regions of several liver-specific genes. (1991) (62)
The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms. (1993) (60)
Transcription of cloned tRNA genes and the nuclear partitioning of a tRNA precursor (1979) (59)
Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections (2015) (59)
Structure and cell‐specific expression of a cloned human retinol binding protein gene: the 5′‐flanking region contains hepatoma specific transcriptional signals. (1985) (59)
Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. (2003) (59)
T‐cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon‐free antiviral regimen in a chimpanzee (2014) (58)
Promoter of a eukaryotic tRNAPro gene is composed of three noncontiguous regions. (1982) (57)
Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. (1998) (56)
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines (2009) (55)
Role of SR-BI in HCV entry: kinetics and molecular 1 determinants 2 (2009) (55)
Circular dichroism study on the conformational stability of the dimerization domain of transcription factor LFB1. (1991) (55)
Engineering human interleukin‐6 to obtain variants with strongly enhanced bioactivity. (1996) (54)
Characterization of human ferritin H chain synthetized in Escherichia coli. (1987) (53)
Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies. (1999) (52)
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants (2016) (52)
Combinatorial libraries : synthesis, screening and application potential (1996) (52)
The X-ray structure of an atypical homeodomain present in the rat liver transcription factor LFB1/HNF1 and implications for DNA binding. (1993) (51)
Sequence of human haptoglobin cDNA: evidence that the α and β subunits are coded by the same mRNA (1983) (51)
Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes (2006) (51)
Development of Animal Models for Adeno-Associated Virus Site-Specific Integration (1999) (50)
Cloning of nematode tRNA genes and their expression in the frog oocyte. (1978) (50)
A recombinant apoA‐1–protein A hybrid reproduces the binding parameters of HDL to its receptor. (1987) (50)
Successful anti‐scavenger receptor class B type I (SR‐BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR‐BI‐targeting agents (2014) (50)
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. (2014) (50)
Coupling protein design and in vitro selection strategies: improving specificity and affinity of a designed beta-protein IL-6 antagonist. (1996) (49)
Transcription signals in embryonic Xenopus laevis U1 RNA genes. (1985) (49)
Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates. (2003) (49)
Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus. (2002) (48)
The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts (2009) (48)
Chromosomal localization in man and rat of the genes encoding the liver-enriched transcription factors C/EBP, DBP, and HNF1/LFB-1 (CEBP, DBP, and transcription factor 1, TCF1, respectively) and of the hepatocyte growth factor/scatter factor gene (HGF). (1992) (46)
Immunization with phage-displayed mimotopes. (1996) (45)
The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice. (1987) (44)
Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus (2013) (44)
Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires (1997) (44)
Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans (2016) (44)
A novel method for site‐directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter. (1982) (43)
Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates (2015) (43)
A POU‐A related region dictates DNA binding specificity of LFB1/HNF1 by orienting the two XL‐homeodomains in the dimer. (1992) (43)
Selection of Potent Inhibitors of Farnesyl-protein Transferase from a Synthetic Tetrapeptide Combinatorial Library* (1996) (41)
Relationship between the two components of the split promoter of eukaryotic tRNA genes. (1982) (41)
Extinction of alpha 1-antitrypsin gene expression in somatic cell hybrids: evidence for multiple controls. (1992) (41)
Cloning and sequencing of a full length cDNA corresponding to human cellular retinol-binding protein. (1985) (39)
Transcription of tRNA genes in vivo: single-stranded compared to double-stranded templates. (1980) (39)
Searching for DNA-protein interactions by lambda phage display. (2002) (39)
Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector (2002) (39)
Enhanced Vaccine-Induced CD8+ T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain (2014) (39)
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist (1997) (38)
The three‐dimensional NMR‐solution structure of the polypeptide fragment 195–286 of the LFB1/HNF1 transcription factor from rat liver comprises a nonclassical homeodomain. (1993) (38)
The transcriptional regulation of liver-specific gene expression. (1991) (38)
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants (2017) (37)
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection (2016) (36)
Transcriptional regulation of liver-specific gene expression (1992) (36)
Characterization of the promoter elements required for hepatic and intestinal transcription of the human apoB gene: definition of the DNA-binding site of a tissue-specific transcriptional factor (1990) (35)
Mapping epitopes on protein surfaces. (1995) (34)
Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates. (2014) (33)
Biotin-tagged cDNA expression libraries displayed on lambda phage: a new tool for the selection of natural protein ligands. (2002) (33)
Mutations in box B of the promoter of a eucaryotic tRNAPro gene affect rate of transcription, processing, and stability of the transcripts (1984) (32)
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies (2018) (31)
Purification of pseudouridylate synthetase I from Salmonella typhimurium. (1978) (29)
Phage-displayed peptides as tools for characterization of human sera. (1996) (28)
Isolation of two cDNAs encoding zinc finger proteins which bind to the alpha 1-antitrypsin promoter and to the major histocompatibility complex class I enhancer (1991) (28)
Cell-specific expression of a transfected human alpha 1-antitrypsin gene. (1985) (28)
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice (2015) (27)
Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes. (2001) (27)
CSF-enriched antibodies do not share specificities among MS patients (1998) (27)
Biosynthesis of pseudouridine in the in vitro transcribed tRNATyr precursor (1977) (27)
The Interleukin-6-dependent DNA-binding protein gene (transcription factor 5: TCF5) maps to human chromosome 20 and rat chromosome 3, the IL6 receptor locus (IL6R) to human chromosome 1 and rat chromosome 2, and the rat IL6 gene to rat chromosome 4. (1991) (27)
Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model. (2015) (27)
Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus. (1999) (26)
Tagging genes with cassette-exchange sites (2005) (26)
Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein. (1998) (26)
Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct‐acting antiviral (2015) (25)
Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors (2014) (24)
Cloning of several cDNA segments coding for human liver proteins. (1983) (23)
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial (2017) (23)
Identification of a novel type 1 diabetes-specific epitope by screening phage libraries with sera from pre-diabetic patients. (1997) (22)
Identification of peptides binding to IgG in the CSF of Multiple Sclerosis patients (1998) (22)
The Kinetics of Hepatitis C Virus-Specific CD8 T-Cell Responses in the Blood Mirror Those in the Liver in Acute Hepatitis C Virus Infection (2008) (22)
The X‐ray structure of an atypical homeodomain present in the rat liver transcription factor LFB1/HNF1 and implications for DNA binding. (1993) (22)
The analysis of the human hemopexin promoter defines a new class of liver-specific genes. (1989) (22)
cDNA sequence coding for human coagulation factor XII (Hageman). (1986) (21)
Application of phage display peptide library to autoimmune diabetes: identification of IA‐2/ICA512bdc dominant autoantigenic epitopes (2002) (21)
Functional mapping of brain synapses by the enriching activity-marker SynaptoZip (2017) (21)
Disruption of the LF‐A1 and LF‐B1 binding sites in the human alpha‐1‐antitrypsin gene has a differential effect during development in transgenic mice. (1991) (21)
Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognize mimotopes of the CD4-like LAG-3 protein. (1996) (21)
Cross-reactive phage-displayed mimotopes lead to the discovery of mimicry between HSV-1 and a brain-specific protein (2001) (20)
Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation* (2014) (19)
Formation of uric acid from adenosylhomocysteine in rat liver (1974) (19)
DNA-based selection and screening of peptide ligands (1998) (19)
Selection of phage-displayed peptides mimicking type 1 diabetes-specific epitopes. (1996) (19)
Mapping of the gene TCF2 coding for the transcription factor LFB3 to human chromosome 17 by polymerase chain reaction. (1990) (19)
Corrigendum: Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice (The Embo Journal (1995) 14 (1932-1941)) (1995) (19)
1H resonance assignment and secondary structure determination of the dimerization domain of transcription factor LFB1. (1991) (18)
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro. (1983) (18)
Site-directed mutagenesis of a tRNA gene: base alterations in the coding region affect transcription. (1982) (17)
Antibody response to respiratory syncytial virus infection in children <18 months old (2016) (17)
One-Step Recovery of scFv Clones from High-Throughput Sequencing-Based Screening of Phage Display Libraries Challenged to Cells Expressing Native Claudin-1 (2015) (17)
A loop-mimetic inhibitor of the HCV-NS3 protease derived from a minibody. (1999) (16)
Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb. (2016) (15)
A novel, inducible, eukaryotic gene expression system based on the quorum‐sensing transcription factor TraR (EMBO reports, February 2003) (Erratum) (2003) (15)
Biosynthesis of tRNA in histidine regulatory mutants of Salmonella typhimurium. (1977) (15)
LFB1/HNF1 acts as a repressor of its own transcription. (1994) (14)
Structure of the human alpha 1-acid glycoprotein gene: sequence homology with other human acute phase protein genes. (1985) (14)
Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication (2017) (13)
Sequences of four tRNA genes from Caenorhabditis elegans and the expression of C. elegans tRNALeu (anticodon IAG) in Xenopus oocytes. (1982) (13)
A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies. (2006) (13)
A functionally orthogonal estrogen receptor-based transcription switch specifically induced by a nonsteroid synthetic ligand. (2005) (13)
Sequence of human haptoglobin cDNA: evidence that the alpha and beta subunits are coded by the same mRNA. (1983) (13)
Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans (2020) (12)
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp 41 epitope (2005) (12)
A negative regulatory element in the promoter of the human α1-antitrypsin gene (1989) (12)
Fractionation of Escherichia coli isoaccepting tRNA species by sepharose 4B column chromatography. (1979) (12)
Characterization of an IL‐6‐responsive Element (IL6RE) Present on Liver‐specific Genes and Identification of the Cognate IL‐6‐dependent DNA‐binding Protein (IL6DBP) a (1989) (12)
The dimerization domain of LFB1/HNF1 related transcription factors: a hidden four helix bundle? (1992) (12)
Transcription of the promoter of the rat NF-1 gene depends on the integrity of an Sp1 recognition site (1990) (12)
Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy (2018) (12)
The Role of tRNA in Regulation (1979) (11)
ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum. (2001) (11)
Processing of eukaryotic tRNA precursors: secondary structure of the precursor specific sequences affects the rate but not the accuracy of processing reactions. (1982) (10)
3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication. (2008) (10)
Identification of disease-specific epitopes. (1998) (10)
A loxP-Containing pol II Promoter for RNA Interference is Reversibly Regulated by Cre Recombinase (2005) (9)
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and nonhepatic origin. (1993) (9)
Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix (2017) (9)
Characterization of a Salmonella typhimurium hisU mutant defective in tRNA precursor processing (1978) (9)
Selective 32P-labelling of individual species in a total tRNA population. (1980) (9)
Adeno‐cosmid cloning vectors for regulated gene expression (2002) (8)
Sequence of a full length cDNA coding for human protein HC (α1microglobulin) (1986) (8)
Review article: HCV ? STAT-C era of therapy (2010) (8)
Differential Screening of Phage-Ab Libraries by Oligonucleotide Microarray Technology (2008) (8)
The human haptoglobin gene promoter: interleukin-6-responsive elements interact with a DNA-binding protein induced by interleukin-6. (1989) (8)
Generation of small mutation in large genomic fragments by homologous recombination: description of the technique and examples of its use. (1990) (7)
A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol (2017) (7)
Transcriptional Control of Gene Expression in Hepatic Cells (1993) (7)
1051 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES (2009) (6)
Safety and Immunogenicity of ChAd 63 and MVA ME-TRAP in West African Children and Infants (6)
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T-Cell Responses (2011) (6)
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries (2019) (6)
Biologically active recombinant prothrombin and antithrombin III expressed in a human hepatoma/vaccinia virus system (1991) (6)
Chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine is safe and expands humoral and cellular immunity in adults (2015) (5)
Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin (2015) (5)
A prokaryotic tRNATyr gene, inactive in Xenopus laevis oocytes, is activated by recombination with an eukaryotic tRNAPro gene. (1982) (4)
Studies on the deamination of L-amino acids in mammalian tissues. (1966) (4)
Functional assay of tRNA molecules transcribed from a purified gene. (1982) (3)
, between Hypervariable Regions 1 and 2 Is Modulated by a Complex Interplay Glycoprotein to CD 81 Is Strain Specific and Binding of the Hepatitis C Virus E 2 (2002) (3)
Three-dimensional structure of the quorum sensing protein TraR bound to its autoinducer and to its target DNA (2002) (3)
Genetic vaccination by gene electro-transfer in non-human primates (2006) (3)
Characterization of an imidazolepyruvic acid reducing system from Escherichiacoli B (1968) (3)
65 A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS (2011) (3)
A database system for handling phage library-derived sequences. (1993) (2)
7 Conformationally Defined Peptide Libraries on Phage: Selectable Templates for the Design of Pharmacological Agents (1996) (2)
Ligand-dependent Transcription Switches and Their Potential for Gene Therapy (2003) (2)
1183 IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION (2012) (2)
Transcription and Processing of Nematode tRNA Genes Microinjected into the Frog Oocyte (1980) (2)
G09 : Targeting a host-cell entry factor barricades antiviral resistant HCV variants from on-therapy breakthrough in human-liver mice (2015) (1)
Transcription of multimeric tRNA genes. (1984) (1)
Regulation of C-Reactive Protein, Haptoglobin, and Hemopexin Gene Expression (2020) (1)
1140 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS (2011) (1)
ThetwoC/EBPisoforms, IL-6DBP/NF-IL6 andC/EBP6/NF- IL6fl, areinduced byIL-6 topromote acute phasegene transcription viadifferent mechanisms (1993) (1)
Gene injection into amphibian oocytes. (1980) (1)
Peptide mimicry of carbohydrate structures (1998) (1)
Crystal structure of Aurora B kinase in complex with Reversine inhibitor (2008) (1)
Vaccination and immunotherapy against bacteria, fungi and parasites (PP-048) (2010) (0)
Selection of epitopes from phage displayed peptide libraries by using human sera: A new tool for the identification of antigenic and immunogenic mimotopes (1994) (0)
Characterization of an imidazolepyruvicacid reducing system from Escherichia coli B +. (1968) (0)
Leo Swadling memory vectors that primes , boosts , and sustains functional HCV-specific T cell A human vaccine strategy based on chimpanzee adenoviral and MVA (2014) (0)
The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in The human alpha-l-antitrypsin gene is efriciently expressed from two tissue-specifilc promotors in transgenic mice (0)
Co-Administration of Chimpanzee Adenoviral Vectors of Different Serotypes, for the Prevention of HCV and HIV Co-Infection (2016) (0)
uses mimotopes of hyper variabele region of e2 glycoprotein of HCV and their (1999) (0)
Engineering humaninterleukin-6 toobtain variants withstrongly enhanced bioactivity (1996) (0)
gene is composed of three (2016) (0)
Muteins of wild type cytokines and their use as immunogenic (1996) (0)
An Apo A-I Protein A Hybrid Used for the Study of HDL Receptor Binding and Endocytosis (1989) (0)
Frameshift mutations induced by an Escherichia coli strain carrying a mutator gene, mutD5 (2004) (0)
Hepatitis C Virus Genotype 1b Vaccine can Benefit Egyptians, where Genotype 4a prevails (2012) (0)
Expression of human alpha-1-acid glycoprotein in human cell lines. (1989) (0)
The use of genetic markers for the selection and the allelic exchange of "in vitro" induced mutations that do not have a phenotype in E. coli. (1984) (0)
Nucleic Acids Research pEMBL: a new family of single stranded plasnids (0)
In vitroselection of peptides from molecular repertoires (1993) (0)
Theaffinity-selecti on ofa minibody polypeptide inhibitor ofhumaninterleukin-6 (1994) (0)
Muteins using wild-type cytokine as immunogens. (1996) (0)
827 EXPERIMENTAL HCV VACCINE COMBINING ADENOVIRUS AND PROTEIN ELICITS POTENT T-CELL RESPONSES AND NEUTRALIZING ANTIBODIES IN RODENTS (2012) (0)
Hdl receptor studies with a hybrid protein containing apoa 1 (1986) (0)
A highly immunogenic novel genetic vaccine against HCV (2012) (0)
Generation and screening of solution-phase synthetic peptide combinatorial libraries (1999) (0)
ANTIBODY DETECTION BY ANTIGEN MIMICS (1996) (0)
Mimotopes of the hypervariable region 1 of HCV E2 glycoprotein and use thereof. (1999) (0)
Antibody Immune Responses Regimen Elicits T Cell and Neutralizing C Virus Envelope Protein Prime-Boost Combined Adenovirus Vector and Hepatitis (2014) (0)
Sequence of a full length cDNA coding for human protein HC (alpha 1 microglobulin). (1986) (0)
Virus DNA Vaccine in Nonhuman Primates by Gene Electrotransfer of a Hepatitis C Modulation of the Immune Response Induced (2006) (0)
THE SOLUTION NMR STRUCTURE OF THE N-TERMINAL PROTEASE DOMAIN OF THE HEPATITIS C VIRUS (HCV) NS3-PROTEIN, FROM BK STRAIN, 20 STRUCTURES (1999) (0)
Interleukin 6induces aliver-specific nuclear protein thatbindsto thepromoter ofacute-phase genes (1989) (0)
Processes for production of immunogenic or diagnostic reagents and just such (1994) (0)
cross-reactive antibody to non-human adenovirus vaccine vectors 2 (2014) (0)
IMMUNOGENICITY OF MALARIA-VECTORED VACCINES IS NOT AFFECTED BY CO-ADMINISTRATION WITH ROUTINE EPI VACCINES IN A RANDOMISED CONTROLLED TRIAL IN GAMBIAN INFANTS AND NEONATES (2017) (0)
8 Discovery of Disease-Specific Mimotopes by Screening Phage Libraries with Human Serum Samples (1996) (0)
A negative regulatory element in the promoter of the human alpha 1-antitrypsin gene. (1989) (0)
Structure and Liver Specific Expression of the Human Retinol Binding Protein Gene (1985) (0)
Expression of human e l-acid glycoproteln genes m cultured cells and m transgemc m ce (1988) (0)
Stefano Colloca Induce Potent Cellular Immunity Across Multiple Species Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses (2011) (0)
Expression system for polynucleotides encoding respiratory syncytial virus (rsv) proteins or variants thereof (2011) (0)
New developments in combinatorial libraries. (1997) (0)
An Ounce of HCV Prevention (2014) (0)
Determination of individual genetic pattern by analysis of hypervariable minisatellites as a new method for establishment of paternity. General considerations and descriptions of a disputed case (1988) (0)
Regulation of the intracellular concentration of T4 induced tRNA (1977) (0)
Mimotopes of the hyper variabelen region 1 of the E2 glycoprotein of HCV uses and their (1999) (0)
[Identification and purification of an alpha-ketoacid aromatic reductase of Escherichia coli B]. (1968) (0)
New vectored vaccines for malaria. (2008) (0)
Solution ensemble structures of HIV-1 gp41 2F5 mAb epitope (2003) (0)
HCV T Cell Re-Vaccination Strategies using Simian Adeno and MVA Viral Vectors to Enhance and Maintain Anti-Viral Immunity (2016) (0)
Thehumanal-antitrypsin geneistranscribed fromtwodifferent promoters inmacrophages andhepatocytes (1987) (0)
Volume 12 Number 2 1984 Nucleic Acids Research Transcription of mulu ' meric tRNA genes (2005) (0)
Hepatitis C Virus-specific immune response among needle-stuck Egyptian healthcare workers at high risk of infection without viremia or seroconversion (2010) (0)
Table of Contents (1991) (0)
Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans. (2020) (0)
Process for preparing immunogens or diagnostic reagents and immunogens or diagnostic reagents obtainable by said process. (1994) (0)
Biochemical andRegulatory Properties ofEscherichia coli (1977) (0)
Identification of a Novel HIV-1 Neutralizing Antibody Using Synthetic Peptides that Mimic a GP41 Fusion Intermediate (2006) (0)
Cloning ofthegenecoding forhumanLapoferritin (1986) (0)
101 HUMAN MONOCLONAL ANTIBODIES TARGETING SR-BI PREVENT HCV ENTRY AND VIRAL SPREAD IN VIVO (2011) (0)
Characterization of the activation domain and post-translational modification of IL-6DBP necessary for induction of acute-phase gene transcription by IL-6 (1991) (0)
IL6fl, are induced by IL-6 to promote acute phase gene transcription via different mechanisms (0)
Polynucleotides and polypeptides of adenovirus (2016) (0)
Trans-acting factors responsible for hepatocyte differentiation (1990) (0)
195 Hepatitis C Virus-Specific Immune Response Among Egyptian Healthcare Workers at High Risk of Infection Without Viremia or Seroconversion* (2011) (0)
Identification of the biological father by means of DNA hypervariable minisatellites in a case of incest (1989) (0)
Prime Site Binding Inhibitors of the Hepatitis C Virus NS3/4A Serine Protease (2001) (0)
Volume 11 Number 12 1983 Nucleic Acids Research A general method to select for M 13 clones carrying base pair substitution mutants constructed in vitro (2004) (0)
A chimpanzee serotype-based adenoviral vector as vaccine for CEA (2006) (0)
Responses to HCV in Man Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Riccardo Cortese?

Riccardo Cortese is affiliated with the following schools:

Riccardo Cortese's Academic­Influence.com Rankings

Riccardo Cortese's Degrees

Why Is Riccardo Cortese Influential?

Riccardo Cortese's Published Works

Published Works

What Schools Are Affiliated With Riccardo Cortese?

Riccardo Cortese's AcademicInfluence.com Rankings